
Worked to Death

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.

If all goes as planned, in three weeks, SpaceX will be public under the ticker SPCX. I’ll say it every time: bear though I may be, I am cheering for SpaceX, since its success is a direct benefit to the Knight clan. Having said that, I would like to caution you that the most recent hot IPO, semiconductor maker Cerebras, had a crazy-hot offering (triple-digit gain the first day) and has been coughing up blood ever since.
Just sayin’.

Here is the second portfolio which, as with the first, managed to survive after eight weeks in a row of S&P gains; there are fewer positions here, but the key one, EFA, is quite large.
Adma Biologics crashed hard, but I think it has more to go. I’ve been tightening up the stop-loss along the way.

Here is one portfolio of the eight short sales which survived this absolute blow torch of a market (with the S&P 500 up eight weeks in a row).
We start with Centene, which has completed a huge rally back up to a massive topping pattern.
